ALLMedicine™ Secondary Prevention of Coronary Artery Disease Center

Apr 26th, 2022 - Digital cardiology is gaining power in the field of preventive cardiology recently, and several trials have already shown good results of dietary therapy with digital cardiology. However, there has been no reports that showed effect of dietary cou...

Jan 17th, 2022 - Colchicine has become prominent as an anti-inflammatory therapy for secondary cardiovascular prevention in patients with coronary artery disease (CAD). This meta-analysis was performed to evaluate the efficacy and safety of colchicine in patients ...

Dec 18th, 2021 - Despite established guidelines on secondary prevention of cardiovascular disease, practical implementation of treatment targets is deficient even in high-income countries. This study compared long-term hospital-based treatment with follow-up at pr...

Oct 22nd, 2021 - Overview Despite relatively recent declines in age-adjusted mortality, in 2013, cardiovascular disease (CVD) was the primary cause in nearly 801,000 deaths (30.8% of total deaths) in the United States. [1] In fact, CVD has been the leading cause o...

Oct 22nd, 2021 - Despite relatively recent declines in age-adjusted mortality, in 2013, cardiovascular disease (CVD) was the primary cause in nearly 801,000 deaths (30.8% of total deaths) in the United States.[1] In fact, CVD has been the leading cause of death in...

Jul 24th, 2008 - The following chapter devoted to antithrombotic therapy for chronic coronary artery disease (CAD) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition...

Apr 26th, 2022 - Digital cardiology is gaining power in the field of preventive cardiology recently, and several trials have already shown good results of dietary therapy with digital cardiology. However, there has been no reports that showed effect of dietary cou...

Sep 12th, 2018 - Dual Antiplatelet Therapy (DAPT) with aspirin and P2Y12 receptor inhibitor remains a cornerstone in the secondary prevention of coronary artery disease (CAD). Clopidogrel is one of the most commonly used antithrombotic agent that inhibits the plat...

Apr 13th, 2016 - Coronary artery bypass grafting (CABG) surgery is often performed in elderly patients, but non-adherence to post-CABG guideline medications is a common and serious clinical concern in this age group. A recent systematic review found that higher me...

Jul 28th, 2015 - BACKGROUND: Despite the abundant evidence base for secondary prevention, practice audits consistently demonstrate substantial "care gaps" between this evidence and clinical reality such that many patients with Coronary Artery Disease (CAD) are not...

Jun 23rd, 2015 - The aim of this study is to test the effectiveness of a smartphone based application (APP) on improvement of patients' adherence to medications after coronary artery bypass grafting. DESIGN AND PROCEDURES The study is a randomized controlled trial...

Sep 1st, 2016 - Percutaneous coronary intervention for acute coronary syndromes has evolved, and so, hand in hand, has antiplatelet therapy. With the advent of clopidogrel and newer agents, several studies demonstrated the benefits of dual antiplatelet therapy in.

Dec 1st, 2014 - PRACTICE CHANGER Prescribe a high-dose statin before any patient with acute coronary syndrome (ACS) undergoes percutaneous coronary intervention (PCI); it may be reasonable to extend this to patients being evaluated for ACS. 1 Strength of recommend.

Jun 13th, 2011 - A group of professional societies on June 13 has issued the first set of quality improvement measures that focus on primary and secondary prevention of coronary artery disease and hypertension in the ambulatory setting. The 10 measures were charac.

BOSTON — Statin therapy significantly reduces the risk of sudden cardiac death independent of its effect on cholesterol, according to a metaanalysis of 12 studies. “This is not a surprise because statins have a variety of effects, and it is these.

BACKGROUND: Observation studies have suggested that hormone replacement therapy (HRT) prevents osteoporotic fractures; however, few randomized trials have been reported. The influential Heart and Estrogen/progestin Replacement Study (HERS) was a r.